Knight Therapeutics Inc. (GUD.TO)
Buys and sells prescription cancer and specialty medicines across Canada and Latin America.
9.84+0.00%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+59.5%
The outlook
GUD.TO trades at 9.84, sitting well above both its 50- and 200-day moving averages and near the top of its 52-week range. Analyst coverage is sparse, with the average target essentially level with the current price. The stock shows a bullish technical setup, though the elevated trailing P/E of 164 suggests limited earnings relative to price.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range93% of the way from its 52-week low to high
Price targetAvg target -0% vs current price
Analyst price target
~12-month · 7 analysts9.83average target-0.1% vs now
Now 9.84
Low 9.00High 12.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$966.1M
52-wk high
10.17
52-wk low
5.66
50-day avg
9.21
200-day avg
7.13
Trailing P/E
164.0